KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
002793 Luoxin Pharmaceuticals Group Stock
- 4.54
- -0.08-1.73%
Market Closed Dec 13 15:00 CST
4.94BMarket Cap-7.08P/E (TTM)
4.72High4.54Low266.54KlotVolume4.61Open4.62Pre Close123.18MTurnover2.45%Turnover RatioLossP/E (Static)1.09BShares5.8052wk High2.35P/B4.93BFloat Cap3.2252wk Low5.08Limit Up1.09BShs Float27.94Historical High4.16Limit Down3.90%Amplitude3.22Historical Low--Dividend TTM4.62Avg Price136.19KlotAsk--Div YieldTTM100Lot Size125.52KlotBid
Luoxin Pharmaceuticals Group Stock Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 2.98%1.88B | 0.30%1.26B | 3.97%688.73M | -34.11%2.36B | -51.55%1.83B | -60.05%1.26B | -69.57%662.43M | -44.62%3.59B | -25.98%3.77B | -8.73%3.14B |
| Operating revenue | 2.98%1.88B | 0.30%1.26B | 3.97%688.73M | -34.11%2.36B | -51.55%1.83B | -60.05%1.26B | -69.57%662.43M | -44.62%3.59B | -25.98%3.77B | -8.73%3.14B |
| Other operating revenue | ---- | -23.82%19.47M | ---- | -70.01%35.27M | ---- | -56.10%25.55M | ---- | 8.60%117.61M | ---- | 14.83%58.21M |
| Total operating cost | 5.58%2.16B | -2.03%1.39B | -1.97%737.87M | -46.29%2.8B | -52.49%2.05B | -55.96%1.42B | -61.97%752.69M | -12.26%5.22B | -4.30%4.31B | 5.65%3.22B |
| Operating cost | 11.51%1.08B | 14.18%753M | 22.91%436.3M | -51.68%1.27B | -56.33%964.73M | -57.24%659.49M | -60.08%354.97M | -18.55%2.63B | -8.57%2.21B | 0.18%1.54B |
| Operating tax surcharges | -2.69%13.78M | 16.67%9.67M | 22.04%5.03M | -47.72%21.25M | -57.26%14.16M | -66.75%8.29M | -73.56%4.12M | -45.43%40.64M | -39.14%33.13M | -26.41%24.92M |
| Operating expense | 11.72%766.65M | -8.46%442.58M | -18.01%203.98M | -44.28%964.01M | -53.61%686.2M | -61.73%483.46M | -72.29%248.78M | -7.31%1.73B | -0.66%1.48B | 12.62%1.26B |
| Administration expense | -10.83%213.64M | -20.68%126.98M | -25.25%63.61M | -25.08%373.84M | -24.63%239.6M | -23.87%160.09M | -14.19%85.1M | 35.88%498.97M | 25.81%317.88M | 27.48%210.28M |
| Financial expense | -17.00%43.77M | -38.63%28.53M | -34.75%13.6M | -46.74%63.35M | -47.64%52.74M | -20.78%46.49M | 1.53%20.84M | 24.29%118.95M | 50.07%100.72M | 30.41%58.69M |
| -Interest expense (Financial expense) | -24.13%47.21M | -34.30%30.78M | -39.19%14.86M | -38.07%75.97M | -33.88%62.22M | -15.78%46.86M | 2.09%24.43M | 16.63%122.67M | 59.64%94.1M | 53.60%55.64M |
| -Interest Income (Financial expense) | 66.19%-3.02M | 61.45%-2.38M | 5.87%-1.27M | 36.58%-9.3M | 15.45%-8.93M | 27.79%-6.16M | 67.78%-1.35M | -48.64%-14.66M | -21.09%-10.57M | -25.55%-8.53M |
| Research and development | -46.03%49.21M | -51.42%30.06M | -60.53%15.35M | -45.16%112.27M | -46.92%91.17M | -50.10%61.88M | -31.86%38.89M | -36.21%204.73M | -24.00%171.75M | -15.08%123.99M |
| Credit Impairment Loss | 109.09%2.24M | 318.86%9.59M | -64.11%908.76K | -176.45%-54.97M | 71.49%-24.6M | 95.86%-4.38M | 102.47%2.53M | 79.51%-19.88M | -6.39%-86.31M | -193.90%-105.79M |
| Asset Impairment Loss | -10.22%-34.8M | -121.14%-12.24M | 89.53%-2.06M | -72.24%-125.15M | -858.86%-31.57M | -335.04%-5.53M | -1,748.05%-19.63M | -1,184.54%-72.66M | 285.86%4.16M | 14.15%2.35M |
| Other net revenue | 53.81%-16.64M | 51.18%12.59M | 141.26%3.97M | -183.27%-145.7M | -346.63%-36.03M | 167.00%8.33M | 89.96%-9.61M | 450.98%174.96M | 123.64%14.61M | 41.95%-12.43M |
| Fair value change income | ---- | ---- | ---- | -301.05%-4.05M | ---- | ---- | ---- | 179.16%2.01M | 232.24%2.04M | --2.49M |
| Invest income | -918.53%-12.34M | -284.45%-6.64M | -185.09%-2.19M | -90.38%15.54M | 27.91%1.51M | 857.11%3.6M | 4,610.20%2.57M | 22,694.40%161.58M | 14.49%1.18M | -58.69%375.85K |
| -Including: Investment income associates | -1,023.65%-12.48M | -289.66%-6.65M | -187.53%-2.2M | 1,671.63%15.85M | --1.35M | --3.51M | --2.51M | --894.93K | ---- | ---- |
| Asset deal income | -106.81%-114.12K | -106.94%-133.6K | -106.42%-13.74K | -801.54%-12.18M | 469.04%1.68M | 31,490.48%1.93M | --214.07K | 152.47%1.74M | 108.15%294.58K | 100.19%6.1K |
| Other revenue | 67.27%28.37M | 72.96%22.01M | 55.32%7.31M | -65.64%35.11M | -81.81%16.96M | -85.57%12.72M | -19.27%4.71M | 71.92%102.18M | 316.79%93.24M | 492.98%88.14M |
| Operating profit | -15.67%-298.56M | 23.68%-118.99M | 54.77%-45.17M | 59.80%-586.48M | 51.09%-258.11M | -67.53%-155.91M | -197.87%-99.88M | -406.01%-1.46B | -200.47%-527.74M | -125.09%-93.07M |
| Add:Non operating Income | -43.16%9.86M | -15.91%9.42M | -78.66%619.25K | 596.80%20.68M | 613.76%17.35M | 660.31%11.21M | 190.02%2.9M | -81.16%2.97M | -73.70%2.43M | -45.05%1.47M |
| Less:Non operating expense | -40.80%2.64M | -53.09%714.87K | -27.21%543.01K | 449.34%38.32M | -50.21%4.46M | -68.89%1.52M | -66.92%745.96K | -4.64%6.98M | 102.42%8.95M | 129.22%4.9M |
| Total profit | -18.81%-291.33M | 24.58%-110.28M | 53.85%-45.1M | 58.71%-604.11M | 54.10%-245.21M | -51.55%-146.23M | -196.95%-97.72M | -401.51%-1.46B | -200.78%-534.26M | -125.97%-96.49M |
| Less:Income tax cost | -36.51%26.27M | -28.13%11.12M | -21.57%4.53M | 180.14%164.81M | 181.67%41.37M | 25.98%15.47M | -62.57%5.78M | -423.57%-205.64M | -167.23%-50.65M | -81.20%12.28M |
| Net profit | -10.82%-317.6M | 24.92%-121.39M | 52.05%-49.63M | 38.84%-768.92M | 40.74%-286.58M | -48.66%-161.69M | -221.27%-103.5M | -398.19%-1.26B | -206.34%-483.61M | -135.51%-108.77M |
| Net profit from continuing operation | -9.35%-315.55M | 26.90%-119.34M | 52.09%-49.17M | 48.09%-773.8M | 40.33%-288.57M | -50.11%-163.27M | -220.24%-102.62M | -453.55%-1.49B | -206.34%-483.61M | -135.51%-108.77M |
| Net income from discontinuing operating | -202.87%-2.05M | -230.53%-2.05M | 47.27%-463.28K | -97.91%4.89M | --1.99M | --1.57M | ---878.55K | --233.41M | ---- | ---- |
| Less:Minority Profit | 8.48%-52.23M | 6.10%-32.68M | 2.23%-12.97M | -232.98%-107.78M | -514.72%-57.07M | -473.18%-34.81M | -461.80%-13.27M | -308.16%-32.37M | -25.46%13.76M | 3.52%9.33M |
| Net profit of parent company owners | -15.62%-265.37M | 30.09%-88.71M | 59.37%-36.66M | 46.03%-661.14M | 53.85%-229.51M | -7.44%-126.89M | -210.47%-90.24M | -401.63%-1.22B | -213.99%-497.37M | -139.73%-118.09M |
| Earning per share | ||||||||||
| Basic earning per share | -19.05%-0.25 | 33.33%-0.08 | 62.50%-0.03 | 29.07%-0.61 | 38.24%-0.21 | -50.00%-0.12 | -233.33%-0.08 | -407.14%-0.86 | -213.33%-0.34 | -140.00%-0.08 |
| Diluted earning per share | -19.05%-0.25 | 33.33%-0.08 | 62.50%-0.03 | 29.07%-0.61 | 38.24%-0.21 | -50.00%-0.12 | -233.33%-0.08 | -407.14%-0.86 | -213.33%-0.34 | -140.00%-0.08 |
| Other composite income | -96.40%212.67K | -83.20%2.19M | 139.13%1.32M | -107.89%-2.06M | -82.55%5.9M | -10.53%13.06M | 50.67%-3.37M | 1,682.57%26.17M | 647.99%33.8M | 630.22%14.59M |
| Other composite income of parent company owners | -96.40%211.93K | -83.20%2.19M | 139.13%1.31M | -107.89%-2.06M | -82.55%5.88M | -10.53%13.01M | 50.67%-3.36M | 1,682.57%26.07M | 647.99%33.69M | 630.22%14.54M |
| Other composite income of minority owners | -96.40%734.21 | -83.20%7.57K | 139.13%4.55K | -107.89%-7.13K | -82.55%20.37K | -10.53%45.08K | 50.67%-11.63K | 1,682.57%90.33K | 647.99%116.71K | 630.22%50.38K |
| Total composite income | -13.08%-317.39M | 19.80%-119.2M | 54.79%-48.31M | 37.38%-770.98M | 37.60%-280.68M | -57.83%-148.64M | -236.11%-106.87M | -393.13%-1.23B | -200.27%-449.8M | -131.03%-94.17M |
| Total composite income of parent company owners | -18.57%-265.16M | 24.02%-86.52M | 62.23%-35.35M | 44.68%-663.2M | 51.77%-223.63M | -9.97%-113.87M | -225.00%-93.59M | -396.42%-1.2B | -207.79%-463.68M | -135.16%-103.55M |
| Total composite income of minority owners | 8.45%-52.23M | 6.00%-32.68M | 2.35%-12.97M | -233.93%-107.79M | -511.09%-57.05M | -470.69%-34.76M | -464.46%-13.28M | -307.65%-32.28M | -24.74%13.88M | 4.19%9.38M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
